These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 12012621)
1. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Ortmann J; Prifti S; Bohlmann MK; Rehberger-Schneider S; Strowitzki T; Rabe T Gynecol Endocrinol; 2002 Apr; 16(2):113-20. PubMed ID: 12012621 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
3. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related]
4. Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action. Di Monaco M; Leonardi L; Gatto V; Gallo M; Brignardello E; Boccuzzi G Anticancer Res; 1995; 15(6B):2581-4. PubMed ID: 8669827 [TBL] [Abstract][Full Text] [Related]
5. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro]. He FJ; Wang J; Niu JZ; Wang JF Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537 [TBL] [Abstract][Full Text] [Related]
6. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Maggiolini M; Donzé O; Jeannin E; Andò S; Picard D Cancer Res; 1999 Oct; 59(19):4864-9. PubMed ID: 10519397 [TBL] [Abstract][Full Text] [Related]
7. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. Liu L; Gudas LJ J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002 [TBL] [Abstract][Full Text] [Related]
8. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. Liu ZJ; Zhu BT J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420 [TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
10. In vitro estradiol-sensitivity characterization of the MCF-7, ZR-75, MDA-MB-231 and T47-D human breast neoplastic cell lines. Camby I; Kiss R Anticancer Res; 1993; 13(6A):2355-60. PubMed ID: 8297158 [TBL] [Abstract][Full Text] [Related]
11. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. Sonne-Hansen K; Lykkesfeldt AE J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75-1 cells. de Launoit Y; Dauvois S; Dufour M; Simard J; Labrie F Cancer Res; 1991 Jun; 51(11):2797-802. PubMed ID: 2032219 [TBL] [Abstract][Full Text] [Related]
14. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism. Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684 [TBL] [Abstract][Full Text] [Related]
15. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern. Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Ueo H; Matsuoka H; Sugimachi K; Kuwano H; Mori M; Akiyoshi T Cancer Res; 1990 Nov; 50(22):7212-5. PubMed ID: 2224855 [TBL] [Abstract][Full Text] [Related]
18. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells. Liang Y; Wu J; Stancel GM; Hyder SM J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260 [TBL] [Abstract][Full Text] [Related]
19. [Testosterone versus dihydrotestosterone effects on permanent squamous epithelial cancer cell lines of the larynx]. Kleemann D Laryngorhinootologie; 1993 Aug; 72(8):402-5. PubMed ID: 8397593 [TBL] [Abstract][Full Text] [Related]
20. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Shamsuddin AM; Yang GY; Vucenik I Anticancer Res; 1996; 16(6A):3287-92. PubMed ID: 9042302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]